PRMT2 and breast carcinoma: The loss of PRMT2 nuclear expression in breast cancer cells is linked to increased cyclin D1 expression via indirectly binding to the AP-1 site on the cyclin D1 promoter, thus promoting breast tumor cell proliferation.